Protara Therapeutics Inc - Asset Resilience Ratio

Latest as of March 2026: 63.07%

Protara Therapeutics Inc (TARA) has an Asset Resilience Ratio of 63.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$121.05 Million

Cash + Short-term Investments

Total Assets

$191.92 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Protara Therapeutics Inc's Asset Resilience Ratio has changed over time. Check Protara Therapeutics Inc (TARA) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Protara Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Protara Therapeutics Inc (TARA) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$121.05 Million	63.07%
Total Liquid Assets	$121.05 Million	63.07%

Asset Resilience Insights

Very High Liquidity: Protara Therapeutics Inc maintains exceptional liquid asset reserves at 63.07% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Protara Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Protara Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%

Annual Asset Resilience Ratio for Protara Therapeutics Inc (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Protara Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	50.56%	$105.90 Million	$209.47 Million	+46.43pp
2024-12-31	4.13%	$7.49 Million	$181.45 Million	-28.79pp
2023-12-31	32.92%	$25.99 Million	$78.95 Million	-20.25pp
2022-12-31	53.18%	$60.24 Million	$113.29 Million	+21.02pp
2021-12-31	32.16%	$55.51 Million	$172.60 Million	--
2020-12-31	0.00%	$0.00	$203.16 Million	--
2019-12-31	0.00%	$0.00	$6.97 Million	--
2018-12-31	10.61%	$2.50 Million	$23.52 Million	-37.07pp
2017-12-31	47.68%	$20.97 Million	$43.98 Million	+36.37pp
2016-12-31	11.32%	$4.92 Million	$43.52 Million	-26.04pp
2015-12-31	37.36%	$25.23 Million	$67.54 Million	+19.96pp
2014-12-31	17.40%	$14.76 Million	$84.80 Million	-24.29pp
2013-12-31	41.69%	$2.36 Million	$5.66 Million	-23.86pp
2012-12-31	65.55%	$5.10 Million	$7.78 Million	--

pp = percentage points

About Protara Therapeutics Inc

NASDAQ:TARA USA Biotechnology

Market Cap

$225.38 Million

Market Cap Rank

#16105 Global

#3790 in USA

Share Price

$4.01

Change (1 day)

+1.01%

52-Week Range

$3.03 - $7.56

All Time High

$664.40